Literature DB >> 15895454

New strategies for the prevention of gastric cancer: Helicobacter pylori and genetic susceptibility.

Pelayo Correa1.   

Abstract

Recently acquired knowledge points to the potential of markedly improved strategies for the prevention of gastric cancer. The International Agency for Cancer Research has reached the conclusion that infection with Helicobacter pylori (H. pylori) is carcinogenic to humans (Group I). The bacterium displays marked genetic heterogeneity. Virulence related genes, especially cag A and vac A s1 m1 are associated with an increased cancer risk. Genetic susceptibility, especially polymorphisms of the cytokine genes may increase cancer risk. Highly susceptible individuals infected with high virulence bacterial genotypes have a markedly increased gastric cancer risk. They should be targeted for endoscopic monitoring to detect advanced precancerous lesions. The state of the art is briefly reviewed and the needed research identified. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895454     DOI: 10.1002/jso.20216

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  10 in total

Review 1.  Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori.

Authors:  Rumiko Suzuki; Seiji Shiota; Yoshio Yamaoka
Journal:  Infect Genet Evol       Date:  2011-12-17       Impact factor: 3.342

2.  Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population.

Authors:  Mansour S Al-Moundhri; Mariam Al-Nabhani; Bassim Al-Bahrani; Ikram A Burney; Ali Al-Madhani; Shym S Ganguly; Said A Al-Yahyaee; Christopher S Grant
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

3.  Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk.

Authors:  Mansour S Al-Moundhri; Manal Al-Khanbashi; Mohammed Al-Kindi; Maryam Al-Nabhani; Ikram A Burney; Abdulaziz Al-Farsi; Bassim Al-Bahrani
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

4.  Cyclooxygenase-2 polymorphisms and the risk of gastric cancer in various degrees of relationship in the Chinese Han population.

Authors:  Yuchun Li; Liping Dai; Jianzhong Zhang; Peng Wang; Yurong Chai; Hua Ye; Jianying Zhang; Kaijuan Wang
Journal:  Oncol Lett       Date:  2011-09-20       Impact factor: 2.967

5.  NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations.

Authors:  Mansour S Al-Moundhri; Mohamed Al-Kindi; Maryam Al-Nabhani; Bassim Al-Bahrani; Ikram A Burney; Ali Al-Madhani; Shyam S Ganguly; Misbah Tanira
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

Review 6.  Novel role of toll-like receptors in Helicobacter pylori - induced gastric malignancy.

Authors:  Kaname Uno; Katsuaki Kato; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 7.  Early gastric cancer: concepts, diagnosis, and management.

Authors:  Hitoshi Katai; Takeshi Sano
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.850

8.  The prognostic significance of whole blood global and specific DNA methylation levels in gastric adenocarcinoma.

Authors:  Mansour S Al-Moundhri; Maryam Al-Nabhani; Letizia Tarantini; Andrea Baccarelli; Jennifer A Rusiecki
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

9.  A changing gastric environment leads to adaptation of lipopolysaccharide variants in Helicobacter pylori populations during colonization.

Authors:  Anna Skoglund; Helene Kling Bäckhed; Christina Nilsson; Britta Björkholm; Staffan Normark; Lars Engstrand
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

10.  Helicobacter suis affects the health and function of porcine gastric parietal cells.

Authors:  Guangzhi Zhang; Richard Ducatelle; Belgacem Mihi; Annemieke Smet; Bram Flahou; Freddy Haesebrouck
Journal:  Vet Res       Date:  2016-10-19       Impact factor: 3.683

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.